Business Description
Invion Ltd
ISIN : AU000000IVX4
Compare
Compare
Traded in other countries / regions
IVX.Australia7C8.GermanyIVIXF.USA IPO Date
2010-02-15Description
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.34 | |||||
| Beneish M-Score | -3.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.34 | |||||
| 9-Day RSI | 43.46 | |||||
| 14-Day RSI | 44.11 | |||||
| 6-1 Month Momentum % | -40 | |||||
| 12-1 Month Momentum % | -40 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.05 | |||||
| Quick Ratio | 2.05 | |||||
| Cash Ratio | 0.77 | |||||
| Days Sales Outstanding | 144.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -147.19 | |||||
| Net Margin % | -152.36 | |||||
| FCF Margin % | -89.36 | |||||
| ROE % | -33.31 | |||||
| ROA % | -31.95 | |||||
| ROIC % | -36.98 | |||||
| 3-Year ROIIC % | -42.2 | |||||
| ROC (Joel Greenblatt) % | -491.46 | |||||
| ROCE % | -31.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2 | |||||
| PB Ratio | 1 | |||||
| EV-to-EBIT | -2.37 | |||||
| EV-to-EBITDA | -2.79 | |||||
| EV-to-Revenue | 3.45 | |||||
| EV-to-FCF | -3.76 | |||||
| Earnings Yield (Greenblatt) % | -42.19 | |||||
| FCF Yield % | -24.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Invion Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3.694 | ||
| EPS (TTM) (A$) | -0.001 | ||
| Beta | 0.16 | ||
| Volatility % | 52.1 | ||
| 14-Day RSI | 44.11 | ||
| 14-Day ATR (A$) | 0.000658 | ||
| 20-Day SMA (A$) | 0.00265 | ||
| 12-1 Month Momentum % | -40 | ||
| 52-Week Range (A$) | 0.002 - 0.008 | ||
| Shares Outstanding (Mil) | 6,766.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invion Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invion Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Invion Ltd Frequently Asked Questions
What is Invion Ltd(ASX:IVX)'s stock price today?
The current price of ASX:IVX is A$0.00. The 52 week high of ASX:IVX is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Invion Ltd(ASX:IVX)?
The next earnings date of Invion Ltd(ASX:IVX) is .
Does Invion Ltd(ASX:IVX) pay dividends? If so, how much?
Invion Ltd(ASX:IVX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers